VPAP III: The Two-Level Pressure Non-Invasive Treatment
The VPAP III by ResMed is a non-invasive ventilation (NIV) device designed to provide an effective therapeutic solution for patients suffering from various respiratory conditions, including obstructive sleep apnea syndrome (OSAS). This device uses a two-level pressure treatment (IPAP and EPAP), ensuring optimal management based on the individual needs of the patient. With its technology, the VPAP III offers exceptional comfort while meeting strict clinical requirements.
One of the main advantages of the VPAP III lies in its two-level pressure modes. These modes allow the delivery of a distinct inspiratory pressure (IPAP) and expiratory pressure (EPAP), tailored to the patient’s respiratory needs. This provides a more personalized treatment compared to devices that use a constant pressure.
The CPAP mode (Continuous Positive Airway Pressure) is one of the basic treatment modes used by the VPAP III, providing continuous pressure to keep the airways open, which is especially helpful for patients suffering from obstructive sleep apnea. In addition to the CPAP mode, the device can be set to operate in spontaneous mode, where the pressure is automatically adjusted according to the patient's breathing, enabling a natural ventilation and perfect synchronization between the patient and the device.
The VPAP III incorporates several technologies aimed at enhancing patient comfort and treatment efficacy. Vsync™ is one of these technologies, allowing for automatic leak management. This feature minimizes pressure drops due to leaks while maintaining precise control of the inspiration, ensuring the patient’s breathing remains stable, even in the presence of unintended leaks in the mask.
TiControl™, another key feature of the VPAP III, enables precise control of inspiratory time. This function adjusts the inspiratory time parameters to meet the specific needs of the patient, for example, for those suffering from chronic obstructive pulmonary disease (COPD) or restrictive lung diseases. The TiMax parameter can be adjusted to prolong the inspiratory phase, while TiMin controls the duration of the expiratory phase, thus providing complete treatment customization based on the patient’s needs.
The VPAP III is designed to deliver effective ventilation and maximum comfort, even during prolonged use. With a noise level below 30 dB, this device operates extremely quietly, allowing the patient to enjoy a pleasant treatment experience without nocturnal disturbances.
The device is also compatible with a heated humidifier, which helps reduce nasal dryness and throat irritation, common side effects of pressure therapies. This integrated humidification function improves comfort and helps maintain treatment adherence by preventing the discomfort often associated with respiratory therapies.
The VPAP III is lightweight (2.3 kg) and compact, making it easy to transport, whether at home or on the go. The device is compatible with 100-240 V outlets, making it a convenient choice for international use. This universal voltage system allows patients to continue their treatment, even when traveling abroad, without worrying about power supply compatibility.
In terms of maintenance, the VPAP III is designed to be easy to maintain. The air filters need to be replaced every six months, and the breathing circuits can be easily cleaned to ensure optimal hygiene conditions. The device is also equipped with smart reminders that notify the patient or healthcare provider when maintenance actions are required.
The VPAP III provides easy access to essential data regarding treatment effectiveness. SpO2 data is available via the ResLink module (optional), providing detailed information on the patient’s oxygenation during treatment. This data can be viewed directly on a computer, allowing for real-time monitoring of treatment effectiveness.
